» Articles » PMID: 11709646

Vagus Nerve Stimulation, Side Effects, and Long-term Safety

Overview
Specialties Neurology
Physiology
Date 2001 Nov 16
PMID 11709646
Citations 109
Authors
Affiliations
Soon will be listed here.
Abstract

Vagus nerve stimulation (VNS) is an accepted therapy for the treatment of refractory epilepsy and now even depression. More than 10,000 people have had the device implanted over a period of 12 years. Initial side effects in the early years such as lower facial weakness and electrode lead breaks have now been resolved. Postoperative infections occur in approximately 3% of patients but can be treated with oral antibiotics. Side effects during the use of VNS are usually related to the "on" phase of stimulation. Common side effects are cough, hoarseness, voice alteration, and paresthesias. These side effects tend to diminish with time. Cognitive side effects often seen with antiepileptic drug use are not reported. The side effect profile of VNS is positive, and this treatment option offers patients with refractory epilepsy prospects of good efficacy with only minor and often resolvable side effects.

Citing Articles

Transcutaneous vagus nerve stimulation as a pain modulator in knee osteoarthritis: a randomized controlled clinical trial.

Elsehrawy G, Ibrahim M, A Moneim N, Hefny M, El Shaarawy N BMC Musculoskelet Disord. 2025; 26(1):68.

PMID: 39828740 PMC: 11744843. DOI: 10.1186/s12891-025-08288-6.


Vagus nerve stimulation (VNS): recent advances and future directions.

Austelle C, Cox S, Wills K, Badran B Clin Auton Res. 2024; 34(6):529-547.

PMID: 39363044 PMC: 11543756. DOI: 10.1007/s10286-024-01065-w.


Refractory Obstructive Sleep Apnea Secondary to Vagal Nerve Stimulation.

Coburn R, Lipford M Cureus. 2024; 16(8):e67402.

PMID: 39310422 PMC: 11414717. DOI: 10.7759/cureus.67402.


Quantifying Vagus Nerve Stimulation Outcomes in Multifocal Refractory Epilepsy: A Model Across Multiple Surgeries.

Zakar R, El Khoury J, Prince G, Boutros M, Yaghi C, Matar M Cureus. 2024; 16(9):e69284.

PMID: 39282479 PMC: 11398724. DOI: 10.7759/cureus.69284.


Neuromodulation guide for the non-neuromodulator clinician: What it is and how it can benefit patients?.

Hoffmann C, Wang J, Ali R, DSouza R Biomol Biomed. 2024; 25(2):304-313.

PMID: 39132949 PMC: 11734817. DOI: 10.17305/bb.2024.10967.